Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Several important new issues have arisen in the management of patients with hypertension. A working party of the British Hypertension Society has therefore reviewed available intervention studies on anti-hypertensive treatment and made recommendations on blood pressure thresholds for intervention, on non-pharmacological and pharmacological treatments, and on treatment goals. This report also provides guidelines on blood pressure measurement, essential investigations, referrals for specialist advice, follow up, and stopping treatment.

[1]  J. Chalmers.  Mild hypertension: A summary of the 1993 World Health Organization/International Society of Hypertension (WHO/ISH) guidelines for the management of mild hypertension Memorandum from a WHO/ISH meeting † , 1994, Journal of internal medicine.

[2]  E. Nelson,et al.  The treatment of mild hypertension study. , 1993, JAMA.

[3]  J. Ménard,et al.  1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. , 1993, Bulletin of the World Health Organization.

[4]  P Hjemdahl,et al.  Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? , 1992, Journal of hypertension.

[5]  A E Fletcher,et al.  Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. , 1992, Hypertension.

[6]  B. Dahlöf,et al.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) , 1991, The Lancet.

[7]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[8]  T. Pickering.  Can ambulatory blood pressure monitoring improve the diagnosis of mild hypertension? , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[9]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[10]  J. Neaton,et al.  Blood Pressure (Systolic and Diastolic) and Risk of Fatal Coronary Heart Disease , 1989, Hypertension.

[11]  J. Cruickshank.  Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. , 1988, BMJ.

[12]  C. Bulpitt,et al.  The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). , 1988, Journal of human hypertension.

[13]  J. Cutler,et al.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. , 1988, Archives of internal medicine.

[14]  D. Betteridge,et al.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. , 1987, British medical journal.

[15]  J. Cruickshank,et al.  BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE , 1987, The Lancet.

[16]  A. Breckenridge.  Treating mild hypertension. , 1985, British medical journal.

[17]  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. , 1970, JAMA.

[18]  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.

[19]  T. Wisniewski,et al.  THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION. , 1964, Lancet.